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5.1 Introduction
A key component for the clinical applicability of neuroprostheses is the
neural electrode, intended to bidirectionally exchange information with the
nervous system, thus allowing recording of nerve signals and stimulation of
nerves and muscles over extended periods of time. A prerequisite for the
application of nerve electrodes is that the implant must be biocompatible.
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Biocompatibility can be defined as “the ability of a material to perform an
appropriate host response in a specific application” (Williams, 1987). The
compatibility between a technical and a biological system can be divided into
structural biocompatibility and surface biocompatibility (Stieglitz, 2004).
Structural biocompatibility refers to the adaptation of the artificial structure
to the mechanical properties of the surrounding tissue, so that the device
design and material properties should adapt to the biological structure of the
target tissue. Surface biocompatibility deals with the interaction of chemical,
physical, and biological properties of the foreign material and the target
tissue. A material can be considered biocompatible if substances are only
released in nontoxic concentrations and the biological environment reacts
only with a mild foreign body reaction and encapsulation with connective
tissue. The design and size, as well as the material choice and the interface
surface, have to ensure stable properties of the electrode-electrolyte interface
throughout the implant lifetime (Navarro et al., 2005). Once implanted, a
neural interface has to remain within the body of the subject for months
or years, so the stability of the materials in the electrode is crucial. The
electrode has to be resistant to corrosion during stimulation and to the
attack of biological fluids, enzymes, and macrophages produced during
the initial foreign body reaction. It must be composed of inert materials,
both passively and when subjected to electrical stimulation, since deterio-
ration of the device may result in implant failure and the release of toxic
products.
The first step to determine if any electrode material is biocompatible is,
on one side, the in vitro study, bringing cell cultures in contact with the mate-
rial and evaluating different parameters as morphological and ultrastructural
changes (Koeneman et al., 2004; Vince et al., 2004), and, on another side, the
in vivo subcutaneous implant of the material to investigate the tissue reaction,
evaluating the thickness of cellular layers that surround the material and the
presence of inflammatory cells (Vince et al., 2004). The following step is the
evaluation of the full electrode device implanted in the target tissue, in this
case the peripheral nerve, chronically, assessing possible functional changes
and structural damage to the nerve as a consequence of the implanted device.
The transverse intrafascicular multichannel electrode (TIME) (Boretius
et al., 2010) is intended to be implanted transversally in the peripheral
nerve and address several subgroups of nerve fibers with a single device.
Therefore, in an initial stage of the TIME project we performed extensive
in vivo studies in order to assess the biocompatibility and safety of TIMEs
after implantation in the rat and the pig.
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5.2 Biocompatibility of the TIME in the Rat Nerve Model
5.2.1 Biocompatibility of the Substrate and Components
Following the standards defined in the ISO-10993 protocol for testing
local effects after implantation of a device, pieces of polyimide substrate
containing deposited iridium oxide (IrOx) as conductor for the active sites
of the device were implanted in the subcutaneous tissue of adult rats during
4 weeks. The hexagonal pieces of polyimide substrate, with a surface of
100 mm2, containing 19 deposited circles of IrOx (occupying a total of
50 mm2) were provided by IMTEK. After shaving and disinfecting the rat
skin, four incisions 1.5 cm long were done bilaterally on the back of the ani-
mals, with a distance of 2.5 cm between incisions. Sterile pieces of polyimide
or of silicone as control, were implanted subcutaneously, one in each pre-
pared subcutaneous pocket. The incisions were then sutured and disinfected.
After 4 weeks, animals were sacrificed, and perfused transcardially with 4%
paraformaldehyde. The implanted specimens were removed with the sur-
rounding skin tissue and processed for histological and immunohistochemical
analyses.
Compared to the intact skin, samples that had the polyimide implant,
as well as silicone sheath implant as control, showed the epidermis and the
connective tissue layer, with normal organization and appearance, as revealed
by hematoxylin-eosin staining (Figure 5.1).
There were not areas of necrotic tissue in the subcutaneous and muscle
layers. However, both silicone and polyimide implants were surrounded
by a dense thin capsule of connective tissue. The thickness of the fibrous
capsule was larger in silicone sections (outer zone: 159± 35 µm; inner zone:
69 ± 21 µm) than in polyimide sections (outer zone: 107 ± 9 µm; inner
zone: 60 ± 7 µm). Immunohistochemical labeling was used to assess the
inflammatory reaction by estimating the presence of macrophages stained
with Iba-1 antibody in the capsule surrounding the implants. In samples
with silicone implants macrophages were present at the inner zone, near
blood vessels, but not at the outer and lateral zones. Sections with polyimide
implants showed also concentration of macrophages in the inner zone, and
lower amount at lateral zones.
Polyimide-based materials have been demonstrated biocompatible with
respect to toxicity (Richardson et al., 1993; Rihová, 1996) as well as to
biostable in other types of electrodes implanted in vivo (Rodrı́guez et al.,
2000; Ceballos et al., 2003; Lago et al., 2007). The histological biocom-
patibility assessment of the tissue surrounding the implants of polyimide
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Figure 5.1 Hematoxylin-eosin staining of representative sections from skin without
implant (A), with a silicone implant (B) and with a polyimide implant ((C), and detail in
(D)). (B) Silicone implants showed a cavity formed during tissue processing (asterisk). White
arrows show the superficial fibrous layer (outer zone). (C) Polyimide implants were embedded
in the fibrous capsule (white arrowheads). The deep fibrous layers of the capsule are also
shown (inner zone, black arrow). Scale bars: 500 µm ((A)–(C)) and 20 µm (D).
containing IrOx dots, selected to fabricate the TIME, indicated good integra-
tion in the skin and subcutaneous tissue of the adult rat. This is in agreement
with previous studies, describing the absence of a gross response to metal-
coated pieces of polyimide or uncoated control silicone (Cogan et al., 2003).
Although the capsule surrounding the implant was observed around both
the unprocessed silicone and the metalized polyimide samples, it was sig-
nificantly thinner in the latter. Macrophages were slightly more abundant
next to polyimide than to silicone samples, but still their density was low,
suggesting a slight degree of inflammatory response around the implanted
materials.
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5.2.2 Biocompatibility of the TIME Implanted in the Rat Nerve
The electrodes used in the study corresponded to the TIME-2 and TIME-3
designs, explained in the previous chapter, and were produced by the
Department of Microsystems Engineering (IMTEK) of the University of
Freiburg. Cleaned and sterilized TIMEs were implanted into the sciatic nerve
of adult rats. In one group (Acute, n = 7) of rats the TIME-2 was implanted
and, in order to evaluate the damage just induced by the surgical implantation
procedure, the electrode was retired after an acute electrical stimulation
protocol was performed. In two other groups (TIME-2 and TIME-3, n = 5
each) a TIME-2 or a TIME-3 were transversally implanted in the sciatic nerve
and remained for 2 months.
The TIME devices were transversally inserted across the three fascicles
of the sciatic nerve (sural, tibial, and peroneal branches) at the midthigh. The
electrode was inserted with the help of a small straight needle attached to a
10-0 loop thread that was passed between the two arms of the TIME. The
needle was inserted transversally across the sciatic nerve and then pulled the
thin-film structure through it. Once the structure was implanted, the needle
was removed by cutting the suture. The TIME-2 ribbon was routed across the
overlying muscular plane to the lateral thigh region, where the ending part
was secured under the skin. For the TIME-3 design, the ribbon was routed
along the nerve and the ending pad was accommodated under the muscle
(Figure 5.2).
All the animals were followed up with a battery of neurophysiological
tests to obtain evidence of possible functional alterations, and final histolog-
ical analysis to assess potential damage induced by the implanted TIMEs
on the nerve. The study design aimed to discriminate effects due to the
implantation procedure, to the presence of the intraneural electrode segment,
and to the mechanical motion induced by the TIME ribbon and connector
during chronic implants (Badia et al., 2011).
During the 2 months implantation time, there were no remarkable changes
in any of the parameters of motor and sensory nerve conduction tests per-
formed in any of the implanted groups, Acute, TIME-2, and TIME-3. The
amplitude of the compound action potentials (CMAPs and CNAPs) obtained
by stimulation of the right sciatic nerve after TIME-2 and TIME-3 implan-
tation did not change notably at any interval postimplantation in comparison
with the control nerve values. There was evidence of slight slowing of nerve
conduction velocity at 7 days in the implanted groups, but it was normalized
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Figure 5.2 Left: Photograph of a TIME-3 in which the intraneural portion is angled at
90◦. Right: photograph of the insertion of a TIME-3 with the ribbon accommodated to the
longitudinal axis of the sciatic nerve.
at 30 days. The implanted nerves showed similar values over time than the
contralateral intact nerves (Figure 5.3A, B).
Walking track test, used to evaluate the locomotion performance, did
not show variations between the right (TIME-2 and TIME-3 implanted)
and left (intact) hindpaw prints along the follow-up. The Sciatic Functional
Index averaged between −5 and +20 during follow-up (Figure 5.3C). The
algesimetry tests yielded similar values of the pain threshold for withdrawal
between the implanted and the contralateral sides, without evidence of hyper-
algesia that might be induced by nerve compression or injury (Figure 5.3D).
No loss of pain sensitivity was appreciated in any area of the hindpaw under
pinprick testing.
5.2.3 Morphological Evaluation of the Implanted Nerves
The macroscopic examination during final dissection at 2 months after
implantation showed that the electrodes remained in place within the sciatic
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Figure 5.3 Neurophysiological tests result in the three groups with Acute, TIME-2, and
TIME-3 chronic implant in comparison with control values. Values of the CMAP amplitude
(A) and onset latency (B) of the tibialis anterior muscle. Values of the SFI (C) and of
algesimetry (D). Modified from Badia et al., 2011.
nerve in all animals of groups TIME-2 and TIME-3. Transverse sections at
the segment that contained the intraneural TIME allowed to see the electrode
strip crossing the fascicles of the sciatic nerve, covered by a fibrous tissue that
disrupted the microarchitecture of the nerve (Figure 5.4).
Transverse semithin sections of the nerve distal to the insertion site
showed a normal fascicular organization (Figure 5.4). The numbers of myeli-
nated fibers counted in the distal level for each of the three branches of
the sciatic nerve were in all the implanted groups similar to those found in
control intact nerves. The reduction of about a 10% in the mean number of
myelinated fibers of the sciatic nerve in group TIME-2 was mostly due to a
decrease of myelinated fibers of about the 8% in the tibial nerve and 25%
in the sural nerve, the smallest of the three branches. Group TIME-3 has
only a small loss of myelinated fibers in the sural nerve (about 20%) (Badia
et al., 2011).
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Figure 5.4 Cross-sections of an implanted rat sciatic nerve. (A) At the level of TIME-3
implant crossing the tibial branch and part of the peroneal branch. Note the mild fibrous
tissue surrounding the electrode. (B) Semithin transverse section of the tibial nerve of the
same animal distal to the implant site. There are no signs of degeneration and the density of
myelinated fibers is similar to controls.
5.3 Biocompatibility of the TIME in the Pig Nerve Model
Device implantation and associated tissue injury trigger a cascade of inflam-
matory and wound healing responses that are typical of a foreign body
response (FBR) (Morai et al., 2010). The continuous presence of biomaterial
devices leads to chronic inflammation. The wound healing response depends
on the size and extent of the implant. The end stage of FBR involves shielding
the implant by a vascular and collagenous fibrous capsule (Williams et al.,
1983; Labat-Robert, 1990; Kovacs et al., 1991). The response to any implant
is wound healing comprised of hemostasis (seconds to hours), inflammation
(hours to days), repair (days to weeks), and remodeling (weeks to months)
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(Stroncek, 2008). To evaluate the biological effect of the TIME electrodes
in the large nerve animal model (chronically implanted Göttingen mini-
pigs), and particularly the fibrotic capsule formed around the electrode, we
harvested and analyzed nerves following several weeks of implant.
All experimental procedures were approved by the Animal Experiments
Inspectorate under the Danish Ministry of Justice. Female, Göttingen mini-
pigs. Under full anesthesia and using aseptic surgical techniques one or two
TIMEs were implanted in the median nerve above the elbow joint. If only
one TIME electrode was implanted, it was placed at an angle of 90◦ or
135◦. When two electrodes were implanted they were implanted with a 45◦
difference in angle. Lead-out wires were tunneled subcutaneously to the back
of the pig where they excited the skin.
To collect tissue for histological evaluation an incision was made over
the implant area and the location of the TIME and the median nerve were
identified. The animal was then euthanized and the nerve including elec-
trode(s) and lead-out wires was harvested. We performed further dissection
of the harvested tissue in order to free the nerve and electrode from the
surrounding fibrotic tissue (Figure 5.5). A specimen of approx. 5 mm of
the nerve containing the TIME electrode was taken and either immersed
in formalin or in liquid nitrogen. To maintain orientation of the nerve the
proximal cross-section was marked with green dye while the entry and the
exit point of the identified TIME electrodes were marked with blue. In one
animal, we collected control samples from the right, nonimplanted leg. We
included 11 animals in the study that were implanted during 22 ± 7.7 days
(range 8–37 days).
Figure 5.5 Example of nerve specimen retrieved from a minipig after approx. 30 days of
implant. The surrounding fibrotic tissue has been removed by careful dissection to identify the
entry and exit points of the TIME.
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Figure 5.6 Typical samples of H&E stains of the peripheral nerve, where the TIME electrode
has been identified inside the nerve. Left (×20, Pig 02): whole nerve with TIME transversing
through the nerve easily identified. Right (×100, Pig 02): higher magnification of the implant
site – the TIME electrode and a layer of fibrosis surrounding the electrode is seen. The visible
“cracks” inside the fascicles result from the processing and embedding the nerve.
Transverse sections of 5 µm thickness were cut in the nerve using a cryo-
stat. The tissue was stained with Hematoxylin and Eosin (H&E) (Figure 5.6).
To estimate the thickness of the fibrotic scarring, digital pictures were taken
through a microscope. To avoid bias we randomly chose five points and
measured the distance from the polyimide structure of the electrode to the
rim of the fibrotic capsule perpendicularly.
5.3.1 Morphological Evaluation of the Implanted Nerves
All animals were in good health state and supported weight on the implanted
leg. In approximately half of the animals we noticed signs of swelling, edema,
and tenderness at the wound following the implant, which disappeared in the
following 6–9 days. Eight of the 13 animals developed infection either at the
implant wound or at the percutaneous connector in the back. In the majority
of the cases we were able to treat the infection to a point where it was not
possible to detect it visually.
Layer of fibrosis. Complete visualization of the entire length of TIMEs placed
transversely through the nerves was not always possible. The estimated layer
of fibrosis is shown in Table 5.1. The thickness of the fibrosis averaged 108±
40 µm. A similar FBR was also identified in the histological evaluation of the
rat sciatic nerve. We found no apparent correlation between the thickness of
the fibrosis and the duration of the implant.
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Table 5.1 Estimated thickness of the fibrotic capsule formed around nine TIME electrodes
implanted in seven pigs
Pig 10 Pig 10 Pig 11 Pig 11
Animal Pig 01 Pig 02 Pig 04 Pig 06 Pig 09 TIME-1 TIME-2 TIME-1 TIME-2
Thickness
[µm]
Mean ± SD
74.3 62.0 179.6 71.4 128.3 116.4 141.6 117.9 100.4
± 8.7 ± 26.5 ± 60.6 ± 23.5 ± 42.9 ± 9.4 ± 30.6 ± 38.9 ± 21.1
# days
implant
36 19 25 20 8 31 31 37 37
Macroscopic changes. For animals included in the “Chronic selectivity”
experiments we found that typical inflammatory cells were present around
the implant (i.e., including lymphocytes, macrophages, and giant cells),
however some variation between animals was observed. Also we identified
fibrocytes/fibroblasts in all animals. There were no signs of necrosis. The
presence of inflammatory cells and fibroblasts/fibrocytes indicated that the
wound healing process was likely still ongoing at the time of explant. It is
important to note that the inflammatory response and the formation was only
found around the electrode, i.e., the remaining part of the nerves and fascicles
appeared normal and without presence of fibrosis or inflammatory response.
5.4 Discussion
Intraneural electrodes are intended to provide a good degree of sensitivity and
selectivity for stimulation and recording action potentials at the nerve fibers
of the implanted nerve fascicles. However, they have the risk of inducing
damage to the nerve. Relative motion between the nerve and surrounding
muscles during limb movement can exert forces on the electrode, and eventu-
ally extract it or damage the nerve if the electrode is unable to move with
the nerve. Lead management and connector requirements offer additional
challenges; lead wires or ribon strips can produce tethering forces on the
electrode, resulting in damage to the nerve or breakage of the device. The
materials used for the TIME, i.e., polyimide as substrate and IrOx as con-
ductive sites, are biocompatible, as corroborated in our study in subcutaneous
implants. The induced FBR was similar or slightly thinner than with a control
substrate as silicone.
In general, we found that all the animals implanted, either rats or pigs,
showed good recovery from the surgery and were in good health during the
implant period. The infections experienced are likely related to the pig model,
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since no infections were observed in the rat model. However, the risk of
infection in future human clinical experiments will be very low, since it is
much easier to keep the percutaneous lead wires and exit points clean and
protected.
From the surgical point of view, TIMEs were easy to implant in the
nerve, because of the high flexibility and small thickness of the electrode
strips, even in the small size nerves of the rat. The results of the follow-up
evaluation indicate that either acute or chronic implantation of the TIME
in the rat sciatic nerve for up to 2 months did not cause significant signs
of axonopathy, axonal loss or demyelination, as evidenced by the functional
and histological findings. Nerve conduction tests showed a mild increase in
latency time at the first week after implantation, which is likely attributable
to the surgical implantation procedure, since damage to the perineurium
leads to endoneurial edema. Nevertheless, the degree of dysfunction was low
and time limited, since the animals showed recovery toward normal values
during the following weeks. Moreover, the nociceptive responses quantified
by algesimetry tests showed a mild decrease of the threshold only at 7
days in the group TIME-2, whereas at 1 and 2 months there were no signs
of hyperalgesia or pain. The absence of differences between the animals
implanted with TIME-3 and their controls indicates that the tethering and
motion forces, produced by the surrounding muscles and transmitted through
the ribbon in the case of the TIME-2 implants, were minimized with the next
TIME-3 design.
Regarding the histological results in the rat implanted nerves, the finding
of a slightly reduced number of myelinated fibers distal to the implant site in
group TIME-2 is suggestive of damage and subsequent axonal degeneration
of a small population of nerve fibers. Nevertheless, we did not find images
of ongoing degenerating fibers at 2 months, thus pointing to a time-limited
damage, most likely occurring during insertion. Comparatively, the reduction
of about a 10% in the number of myelinated nerve fibers with TIME-2 in the
chronic group is similar to that previously reported after the implantation of
other intrafascicular electrodes such as the polyimide thin film LIFE (Lago
et al., 2007), which is coherent with the fact that the Young’s modulus of the
substrate material (polyimide, UBE U-Varnish-S) is similar between TIME
and LIFE. The Utah Slanted Electrode Array (USEA) that is also inserted
transversally to the nerve yielded results similar to the ones found for the
TIME, although we did not find images of ongoing degenerative fibers at 2
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months postimplant, in contrast with the results for the USEA (Branner et al.,
2004); the difference may be attributed to the stiffness of the silicon USEA
structure.
The reduction in the number of myelinated nerve fibers in the tibial nerve
of the group TIME-2 was not observed in the group TIME-3. This difference
can be explained because of the absence of traction forces with the TIME-
3 design, this conclusion is reinforced by the fact that the nerves of the
Acute group did not show fiber loss. The minor loss of myelinated fibers
in group TIME-2 was not extensive enough to affect the animal function
or electrophysiological responses. Since in group TIME-3 we did not find
significant histological abnormalities, we can attribute most of the axonal loss
in group TIME-2 to the effects produced by the traction forces for some days
after implantation during the animal motion, and not to the material itself.
The refinement in the geometrical design of the TIME-3 allows for a better
adaptation of the structure to the anatomical properties of the nerve and to
reduce the tethering forces to which the electrode may be subjected.
These conclusions were proved by the subsequent study of TIME-3
implants in the pig median nerve. There were no clinical evidences of nerve
damage or dysfunction during several weeks of implant. The histological
study of the harvested nerves did not show any appraten abnormality on
the microstructure of the nerve, except for the presence of the transversal
electrode, which was covered by a fibrous capsule, as corresponds to a
normal FBR. The overall mean of the fibrosis was 108 ± 40 µm, which is
comparable to what is found in the literature (Williams et al., 1983; Labat-
Robert, 1990; Kovacs et al., 1991). A similar reaction and layer of fibrosis
was also identified in the histological evaluation of the rat sciatic nerve.
Interestingly, there was no apparent correlation between the thickness of the
fibrotic scarring and the duration of the implant, thus suggesting that the FBR
occurs during the first 1–2 weeks after implant, and thereafter remains stable,
helping also to maintain the implanted electrode in place. The inflammatory
response and fibrosis was only found around the electrode, i.e., the remaining
part of the nerves appeared normal.
Altogether our results indicated that the TIMEs are biocompatible and
safe after chronic implantation even in a small peripheral nerve, such as the
rat sciatic nerve. The mild effects of the TIME on the nerve will be minimized
when implanting the electrode of the same dimensions in larger nerves of
humans.
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